High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer | |
Jing, Wang; Wang, Shijiang; Ding, Xiao; Guo, Hongbo; Li, Ji; Wang, Haiyong; Kong, Li; Yu, Jinming; Zhu, Hui | |
刊名 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
![]() |
2018 | |
卷号 | 11期号:5页码:2675-2682 |
关键词 | Small cell lung cancer PD-L1 immunohistochemistry overall survival prognostic factor |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4564957 |
专题 | 山东大学 |
作者单位 | Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, 440 Jiyan Rd, Jinan 250117 |
推荐引用方式 GB/T 7714 | Jing, Wang,Wang, Shijiang,Ding, Xiao,et al. High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,2018,11(5):2675-2682. |
APA | Jing, Wang.,Wang, Shijiang.,Ding, Xiao.,Guo, Hongbo.,Li, Ji.,...&Zhu, Hui.(2018).High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,11(5),2675-2682. |
MLA | Jing, Wang,et al."High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 11.5(2018):2675-2682. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论